Clinical trial
Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of…
NCT00294320 · MEDA Pharma GmbH & Co. KG, Industry · Completed
Key facts
| NCT number | NCT00294320 |
|---|---|
| Title | Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions |
| Official title | Pilot Study to Evaluate Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions (Clinical and Sub-clinical), When Treated With Aldara 5% (Imiquimod) Cream |
| Lead sponsor | MEDA Pharma GmbH & Co. KG, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Actinic Keratosis |
| Intervention type | Drug, Other |
| Interventions | Aldara (Imiquimod), Vehicle cream |
| Enrollment | 12 |
| Start date | Feb 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Feb 22, 2006 |
| Last update posted | Feb 7, 2022 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: